Stay updated with breaking news from Membrane Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $21.17, but opened at $20.71. Bicycle Therapeutics shares last traded at $20.70, with a volume of 2,398 shares changing hands. Analysts Set New Price Targets Several analysts have recently weighed in […]
Logos Global Management LP cut its holdings in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 47.7% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 750,000 shares of the company’s stock after selling 685,000 shares during the period. Bicycle Therapeutics comprises approximately 2.3% of Logos Global […]
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) dropped 2.7% on Wednesday . The stock traded as low as $23.17 and last traded at $23.20. Approximately 17,700 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 272,389 shares. The stock had previously closed at $23.85. Wall […]
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) was the recipient of a large decline in short interest in the month of July. As of July 31st, there was short interest totalling 3,740,000 shares, a decline of 13.2% from the July 15th total of 4,310,000 shares. Based on an average daily volume of 223,800 shares, […]
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nine analysts that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month price objective […]